ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1429	National Cancer Institute	Html	en	Neuroblastoma Screening (PDQ®)–Patient Version	Expert-reviewed information summary about tests used to detect or screen for neuroblastoma.	cancer treatment 0.486632 cancer screening methods 0.582299 ongoing clinical trials 0.502871 neuroblastoma 0.698844 PDQ cancer information 0.80843 false-negative test result 0.502128 NCI Web site 0.507263 clinical trials 0.709878 vanillyl mandelic acid 0.576656 test result 0.623055 nerve tissue 0.489507 cancer information summary 0.657568 clinical trial 0.522829 breast cancer prevention 0.512391 diagnostic tests 0.506931 test results 0.491146 false-positive test result 0.501632 PDQ summaries 0.524226 latest published information 0.506403 PDQ® Screening 0.491512 NCI’s PDQ 0.527909 cancer symptoms 0.501892 NCI PDQ cancer 0.598105 PDQ Neuroblastoma Screening 0.65982	tests 0.548148 routine screening test 0.556554 Neuroblastoma Treatment 0.531296 new cases 0.489109 PDQ Screening 0.567089 screening tests 0.516882 homovanillic acid 0.494688 Cancer Information Service 0.531924 urine test result 0.504837 Prevention Editorial Board 0.562279 treatment clinical trials 0.501764 National Cancer Institute 0.643496 PDQ documents 0.515811 new treatment 0.51605 health professional version 0.484258 Cancer screening trials 0.58895 PDQ database 0.522175 Cancer Care page 0.516301 adrenal glands 0.539844 PDQ summary 0.591543 cancer information summaries 0.540208 health professional versions 0.487782 comprehensive cancer information 0.541053 cancer 0.90999	CLICK HERE
1442	National Cancer Institute	Html	en	Cancer Genetics Risk Assessment and Counseling (PDQ®)–Health Professional Version	Expert-reviewed information summary in which cancer risk perception, risk communication, and risk counseling are discussed. The summary also contains information about recording and analyzing a family history of cancer and factors to consider when offering genetic testing.	founder pathogenic variants 0.545253 empiric cancer risk 0.604134 cancer family histories 0.596956 cancer history data 0.547429 family cancer history 0.660687 BRCA1/BRCA2 genetic testing 0.54809 cancer risk management 0.587191 pathogenic variant probability 0.552774 hereditary cancer syndromes 0.558149 individual cancer risk 0.61901 hereditary cancer syndrome 0.566539 risk factors 0.556301 colorectal cancer 0.654372 pathogenic variant 0.790487 pathogenic variant risk 0.567786 ovarian cancer 0.54855 cancer risk assessment 0.697386 genetic cancer risk 0.622505 specific cancer risk 0.6007 relative risk 0.558342 cancer genetic risk 0.626613 pdq cancer genetics 0.575741 cancer genetic counseling 0.651461 cancer risk estimates 0.637042 family health history 0.593593	cancer risks 0.557149 cancer genetic counselling 0.564248 genetic tests 0.578519 genetic risk assignment 0.579316 family pathogenic variant 0.554782 genetic counseling 0.788203 risk breast cancer 0.592583 cancer susceptibility genes 0.585996 cancer family history 0.683221 pathogenic variants 0.673985 cancer risk estimate 0.588742 cancer risk calculations 0.583873 hereditary cancer risk 0.589876 cancer susceptibility 0.634338 breast cancer risk 0.620741 breast cancer 0.723734 cancer susceptibility gene 0.59457 family history 0.997369 genetic testing 0.827733 cancer risk 0.781419 hereditary cancer 0.608333 cancer 0.974451 risk 0.868438 Cancer Genetics Services 0.548203	CLICK HERE
1443	National Cancer Institute	Html	en	Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of plasma cell neoplasms (including multiple myeloma).	myeloma progression 0.386014 Lancet Oncol 0.385708 Rajkumar SV 0.402453 Myeloma Working Group 0.489063 stage multiple myeloma 0.418561 elderly multiple myeloma 0.451304 Br J Haematol 0.413842 Engl J Med 0.487061 newly diagnosed myeloma 0.445606 Myeloma Aredia 0.375106 monoclonal gammopathy 0.361847 symptomatic multiple myeloma 0.40517 Richardson PG 0.360951 Dimopoulos MA 0.411188 Myeloma Study Group 0.419959 multiple myeloma study 0.395149 Myeloma IX Trial 0.378652 NCRI Myeloma 0.373496 untreated multiple myeloma 0.466976 dexamethasone 0.382475 multiple myeloma 0.921615	European Myeloma Network 0.377714 autologous stem cell 0.362333 multiple myeloma patients 0.518428 Abstract 0.612448 Kyle RA 0.359131 therapy 0.359069 Clin Oncol 0.527005 International Myeloma Working 0.490739 Clin Lymphoma Myeloma 0.405037 novo multiple myeloma 0.392374 Myeloma Trialists 0.387014 refractory multiple myeloma 0.483265 advanced multiple myeloma 0.41891 Nordic Myeloma Study 0.418541 blood 0.413404 lenalidomide-refractory multiple myeloma 0.403712 plasma cell myeloma 0.383069 refractory myeloma 0.377628 active myeloma 0.392608 multiple myeloma refractory 0.398347 et al. 0.58043	CLICK HERE
1749	National Cancer Institute	Html	en	Helicobacter pylori and Cancer	A fact sheet about the relationship between H. pylori infection and gastric cancer, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, and other cancers.	gastric malt lymphoma 0.326658 M. Gastric cancer 0.212884 H. pylori 0.843788 H. pylori colonization 0.258268 gastric cancer rates 0.221795 cagA-negative H. pylori 0.255803 Helicobacter pylori infection 0.310803 gastric adenocarcinoma 0.207225 Helicobacter pylori 0.602968 F. Helicobacter pylori 0.25223 noncardia gastric cancer 0.213325 non-cardia gastric cancer 0.587912	H. pylori infection 0.660511 caga-positive h. pylori 0.364356 gastric cancer 0.957743 M. Helicobacter pylori 0.251667 Helicobacter pylori CagA 0.252645 Helicobacter pylori seropositivity 0.402047 gastric cancer incidence 0.328991 Overall gastric cancer 0.233481 esophageal adenocarcinoma 0.208828 et al 0.379167 pylori infection rates 0.297929 gastric cardia cancer 0.470154	CLICK HERE
1860	National Cancer Institute	Html	es	Tratamiento del cáncer de laringe (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del cáncer de laringe.	quimioterapia simultánea vs 0.243512 Long-term results 0.234954 radioterapia quizás 0.299585 Zhang Q 0.273545 T4b Enfermedad 0.236466 locally advanced larynx 0.275768 American Cancer Society 0.251609 Pfister DG 0.231071 laringectomía supraglótica 0.243655 Laryngeal Cancer Study 0.26012 nonsurgical treatment 0.254566 laryngeal cancer 0.299143 carcinoma among adult 0.240831 Radiat Oncol Biol 0.820998 DeVita VT Jr 0.253188 glottic larynx treated 0.257222 randomized trial comparing 0.232167 Forastiere AA 0.248924 radiation therapy 0.367315 Head Neck Surg 0.26729 Mendenhall WM 0.301851 with radiotherapy 0.237817 Head Neck 0.3155 cartílago tiroides 0.252905 squamous-cell carcinoma 0.25702	Pajak TF 0.243693 laryngeal carcinoma 0.232948 laringe t1 0.234844 radioterapia posoperatoria 0.379297 Otolaryngol Head Neck 0.267871 múltiples ganglios 0.238357 induction chemotherapy followed 0.233331 local control 0.243042 Clin Oncol 0.490486 Werning JW 0.23125 Oncol Biol Phys 0.857199 glottic carcinoma 0.24993 trial comparing 0.233043 versus concurrent chemoradiotherapy 0.238876 estadio iii 0.267441 neck cancer 0.97371 with or without 0.274489 ganglios linfáticos retrofaríngeos 0.238975 glottic carcinoma among 0.246513 locally advanced 0.370885 Cancer Study Group 0.254186 induction chemotherapy 0.25147 neck carcinoma 0.234046 squamous cell carcinoma 0.852023	CLICK HERE
1968	National Cancer Institute	Html	es	Tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del cáncer escamoso metastásico de cuello con tumor primario oculto.	PDQ Tratamiento 0.637237 glándula tiroides 0.630286 tratamiento.Ciertas formas 0.62926 siguientes procedimientos 0.80319 alta potencia 0.638988 presente sección 0.626186 Physician Data Query 0.682277 rayos x 0.641083 pequeñas marcas 0.628464	cáncer.ampliar radioterapia 0.682908 siguientes enlaces 0.620289 vías respiratorias 0.946667 National Cancer Institute 0.61827 siguientes riesgos 0.612805 siguientes pruebas 0.658061 Instituto Nacional 0.682711 hormonas tiroideas 0.630783 malla ayuda 0.628658	CLICK HERE
3458	National Cancer Institute	Html	es	Aromaterapia y aceites esenciales (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del uso de la aromaterapia y los aceites esenciales para mejorar la calidad de vida de los pacientes de cáncer.	QueaseEaseâ„¢ essential oil 0.322888 Palliat Nurs 0.354113 with dementia 0.319927 Using aromatherapy 0.319114 Adv Nurs 0.330674 aromatherapy massage benefit 0.323369 aromatherapy massage 0.460246 aceite portador 0.411771 effects upon inhalation 0.330851 with sedative effects 0.339649 Essential oils as 0.328315 essential oils with 0.364947 sedative effects upon 0.328613 Estados Unidos 0.358013 Wilkinson S 0.324749 Complement Ther Nurs 0.326064 Ther Nurs Midwifery 0.325274 An evaluation 0.330236 essential oil against 0.321713 Inhalation aromatherapy during 0.319826 patients with 0.403468 essential oil from 0.322691 lavandula vera dc 0.321359 randomized controlled 0.329336 essential oils 0.975981	malignant brain tumours 0.320542 Altern Complement Med 0.328888 wound care 0.337271 células madre 0.337232 contact dermatitis from 0.318516 Essential Oil Therapeutics 0.348142 frecuencia escogen aceites 0.330608 palliative care 0.34198 using essential oils 0.330409 Antibacterial essential oils 0.327832 New York 0.317733 Fragrance compounds 0.318588 Lavandula angustifolia 0.324093 Palliat Med 0.41168 Inhalation aromatherapy 0.326733 verdaderos aceites 0.357046 Van Toller S 0.322917 lavandula angustifolia miller 0.322367 Reino Unido 0.345706 from essential oils 0.326193 Aromatherapy as 0.327736 Essential Oil Blends 0.324181 oils with sedative 0.344081 Dodd GH 0.321815	CLICK HERE
4249	National Cancer Institute	Html	en	Vaccine Therapy for Unresectable Chordoma	In this phase II clinical trial, adult patients with inoperable chordoma who are scheduled to undergo radiation therapy will be randomly assigned to receive a yeast-based vaccine that targets a protein called brachyury or a placebo injection.	cancer vaccine 0.534872 normal adult tissue 0.528641 immune cell 0.47865 nonirradiated tumors 0.477218 overall response rate 0.514452 yeast cells 0.658954 Locally Advanced Chordoma 0.746841 targets brachyury 0.477414 chordoma 0.972044 tumor behavior 0.49462 adjuvant radiation therapy 0.576614 notochord cells 0.571698 small amounts 0.473793 radiation therapy 0.780229 brachyury vaccine 0.530311 tumor types 0.495175 NCI Center 0.485799 spine forms 0.477842 unresectable localized chordoma 0.680351 unresectable chordoma 0.714897 human brachyury protein 0.536106 experimental vaccine 0.525401 trial contact information 0.525243 United States 0.477985 Dr. Christopher Heery 0.538194	unirradiated tumor 0.498179 Drug Administration 0.474087 cancer cells 0.605559 irradiated tumor 0.517748 chordoma cells 0.729894 Treating Patients 0.48917 main treatment 0.476402 embryonic cells 0.554159 NCI Clinical Trials 0.525164 normal adult cells 0.609554 irradiated tumors 0.540538 tumor growth 0.505122 Cancer Research 0.485391 tumor cells 0.567871 Dr. Heery 0.484528 rare type 0.476522 chordoma patients 0.695766 chordoma tumors 0.646987 Chordoma Foundation 0.62992 yeast-brachyury vaccine 0.59967 Dendritic cells 0.55211 immune cells 0.606104 vaccine 0.650607 principal investigator 0.554808	CLICK HERE
15483	National Cancer Institute	Html	es	Cuidados de supervivencia para niños	null	leucemia linfocítica aguda 0.311324 tanta frecuencia 0.308963 Oncología Infantil 0.307626 familias sentimientos 0.30901 cuáles efectos tardíos 0.34751 efectos tardíos 0.975983	niño.  pida recomendaciones 0.316996 cuáles síntomas 0.30742 altas dosis 0.306279 determinados cánceres 0.306277 ¿por cuánto tiempo 0.310201 efectos cognitivos tardíos 0.415505	CLICK HERE
17189	National Cancer Institute	Html	en	Sexual Health Issues in Women with Cancer	Cancer treatments such as chemotherapy, hormone therapy, and radiation may cause sexual problems in women. Conditions may include vaginal dryness, vaginal stenosis, and vaginal atrophy. Learn how to manage and treat these sexual problems.	cancer treatment 0.51645 vaginal tissue 0.532819 primary ovarian insufficiency 0.548774 endocrine therapy 0.478386 health care team 0.776749 sexual life 0.612375 support group 0.540233 gynecologic cancers 0.477639 social worker 0.530013 pelvic muscles 0.474973 sexual activity 0.559668 sexual health 0.668647 sexual intercourse 0.555683 low estrogen levels 0.65848 hair loss 0.473268 physical changes 0.478751 birth control 0.564552 Fertility Issues 0.55759 effects 0.479305 sexual problems 0.5327 hot flashes 0.548172 radiation therapy 0.542011 long term 0.480571 valuable suggestions 0.473342 vaginal dryness 0.649951	vaginal gels 0.527917 problems 0.541005 women 0.505517 cancer treatments 0.472282 treatment 0.973526 sex life 0.471664 personal health factors 0.547006 vaginal secretions 0.525892 cancer-related support services 0.536181 changes 0.511207 Vaginal stenosis 0.532538 vaginal wall 0.531486 vaginal atrophy 0.531565 hormone therapy 0.536753 sexual changes 0.501579 bladder retention 0.472634 shorter vagina 0.48061 sexual health expert 0.553722 support groups 0.47572 Breast Cancer 0.475837 doctor 0.494029 bowel function 0.475187 national organizations 0.470856 time 0.509374	CLICK HERE